Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Dividends payables (2016 - 2020)

Medifast's Dividends payables history spans 6 years, with the latest figure at $13.8 million for Q4 2020.

  • For Q4 2020, Dividends payables rose 0.82% year-over-year to $13.8 million; the TTM value through Dec 2020 reached $13.8 million, up 0.82%, while the annual FY2020 figure was $13.8 million, 0.82% up from the prior year.
  • Dividends payables reached $13.8 million in Q4 2020 per MED's latest filing, up from $13.7 million in the prior quarter.
  • In the past five years, Dividends payables ranged from a high of $13.8 million in Q4 2020 to a low of $4.0 million in Q4 2016.
  • Average Dividends payables over 5 years is $9.4 million, with a median of $9.1 million recorded in 2018.
  • Peak YoY movement for Dividends payables: skyrocketed 51.15% in 2017, then grew 0.82% in 2020.
  • A 5-year view of Dividends payables shows it stood at $4.0 million in 2016, then soared by 51.15% to $6.1 million in 2017, then soared by 49.66% to $9.1 million in 2018, then soared by 50.15% to $13.7 million in 2019, then increased by 0.82% to $13.8 million in 2020.
  • Per Business Quant, the three most recent readings for MED's Dividends payables are $13.8 million (Q4 2020), $13.7 million (Q4 2019), and $9.1 million (Q4 2018).